Glyconjugate Vaccines
US-2024382585-A1 · Nov 21, 2024 · US
US9314518B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9314518-B2 |
| Application number | US-201414176199-A |
| Country | US |
| Kind code | B2 |
| Filing date | Feb 10, 2014 |
| Priority date | Mar 9, 2010 |
| Publication date | Apr 19, 2016 |
| Grant date | Apr 19, 2016 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
Methods of treating a Streptococcus pneumoniae infection are described herein.
Opening claim text (preview).
The invention claimed is: 1. A method of treating a Streptococcus pneumoniae infection in a mammal comprising: (a) measuring the amount of bound and free Zn2+ in the blood serum of a mammal; (b) selecting a mammal having a bound and free Zn2+ concentration in blood serum of less than 2 μM; and (b) administering an immunogenic composition comprising a pharmaceutically effective amount of PhtD to the mammal selected in step (b). 2. The method of claim 1…
Related publications grouped by family.
Free tools are coming soon. Tell us what you want to track and we'll notify you.
Answers are generated from the same data shown on this page.